Skip to content

News

Related Articles

 

CHI Policy Agendas Outline Priorities for 2009

Submitted on: 03.02.2009

In what promises to be a turbulent and challenging year ahead at the state and federal levels, CHI will focus resources in the following public policy areas:

  • FDA regulatory policies and process, including follow-on biologics and preemption; Government coverage and reimbursement policies, including comparative effectiveness research;
  • Biomedical research and education, including NIH and NSF funding and workforce development; Intellectual property, including patent reform;
  • Business and regulatory environment, including state and federal tax policies; Environmental issues.
Click here to read CHI’s federal and state policy agendas.



Back to News Items